13-20142746-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021954.4(GJA3):​c.543C>T​(p.Cys181Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0351 in 1,613,678 control chromosomes in the GnomAD database, including 1,469 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 153 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1316 hom. )

Consequence

GJA3
NM_021954.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0710

Publications

7 publications found
Variant links:
Genes affected
GJA3 (HGNC:4277): (gap junction protein alpha 3) The protein encoded by this gene is a connexin and is a component of lens fiber gap junctions. Defects in this gene are a cause of zonular pulverulent cataract type 3 (CZP3). [provided by RefSeq, Jan 2010]
GJA3 Gene-Disease associations (from GenCC):
  • cataract 14 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset posterior polar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulverulent cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 13-20142746-G-A is Benign according to our data. Variant chr13-20142746-G-A is described in ClinVar as Benign. ClinVar VariationId is 261458.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.071 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0324 (4929/152336) while in subpopulation NFE AF = 0.0415 (2821/68020). AF 95% confidence interval is 0.0402. There are 153 homozygotes in GnomAd4. There are 2602 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 4929 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021954.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJA3
NM_021954.4
MANE Select
c.543C>Tp.Cys181Cys
synonymous
Exon 2 of 2NP_068773.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJA3
ENST00000241125.4
TSL:3 MANE Select
c.543C>Tp.Cys181Cys
synonymous
Exon 2 of 2ENSP00000241125.3
ENSG00000299362
ENST00000762843.1
n.133+4744G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0324
AC:
4929
AN:
152218
Hom.:
153
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00620
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0200
Gnomad ASJ
AF:
0.0239
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00889
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0415
Gnomad OTH
AF:
0.0186
GnomAD2 exomes
AF:
0.0342
AC:
8576
AN:
250712
AF XY:
0.0346
show subpopulations
Gnomad AFR exome
AF:
0.00457
Gnomad AMR exome
AF:
0.0103
Gnomad ASJ exome
AF:
0.0215
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.126
Gnomad NFE exome
AF:
0.0413
Gnomad OTH exome
AF:
0.0391
GnomAD4 exome
AF:
0.0354
AC:
51742
AN:
1461342
Hom.:
1316
Cov.:
35
AF XY:
0.0350
AC XY:
25414
AN XY:
727008
show subpopulations
African (AFR)
AF:
0.00469
AC:
157
AN:
33478
American (AMR)
AF:
0.0110
AC:
490
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0230
AC:
601
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0104
AC:
893
AN:
86258
European-Finnish (FIN)
AF:
0.128
AC:
6788
AN:
53042
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.0369
AC:
41036
AN:
1111864
Other (OTH)
AF:
0.0287
AC:
1734
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3218
6435
9653
12870
16088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1402
2804
4206
5608
7010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0324
AC:
4929
AN:
152336
Hom.:
153
Cov.:
33
AF XY:
0.0349
AC XY:
2602
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00618
AC:
257
AN:
41596
American (AMR)
AF:
0.0200
AC:
306
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0239
AC:
83
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00890
AC:
43
AN:
4832
European-Finnish (FIN)
AF:
0.129
AC:
1363
AN:
10600
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0415
AC:
2821
AN:
68020
Other (OTH)
AF:
0.0184
AC:
39
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
248
496
743
991
1239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0380
Hom.:
204
Bravo
AF:
0.0220
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.0334
EpiControl
AF:
0.0320

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cataract 14 multiple types Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.7
DANN
Benign
0.68
PhyloP100
0.071
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74607195; hg19: chr13-20716885; API